A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

Clinical trial NCT05929066 · COMPLETED

Trial details

NCT number: NCT05929066
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight Osteoarthritis, Knee Obstructive Sleep Apnea

Start date: 2023-07-10
Primary completion: 2026-04-06
Enrollment: 2335

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.